(c) 2024 PillSync.com

24 HR Propranolol Hydrochloride 160 MG Extended Release Oral Capsule

INDICATIONS AND USAGE Hypertension: Propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride extended-release capsules are not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis: Propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Migraine: Propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Hypertrophic Subaortic Stenosis: Propranolol hydrochloride extended-release capsules improve NYHA functional class in symptomatic patients with Hypertrophic Subaortic Stenosis.

Zydus Pharmaceuticals (USA) Inc.


4 years ago CAPSULE BLUE ZA 60 160 mg 24 HR Propranolol Hydrochloride 160 MG Extended Release Oral Capsule

CAPSULE BLUE ZA 60 160 mg

HOW SUPPLIED

PROPRANOLOL HYDROCHLORIDE Extended-release capsules USP, 60 mg are white to off-white, free flowing pellets filled in size '3' hard gelatin capsules with white colored cap printed with "ZA-57" in black ink and light blue body printed with "60 mg" in black ink and are supplied as follows: NDC 68382-161-16 in bottle of 90 capsules NDC 68382-161-01 in bottle of 100 capsules NDC 68382-161-05 in bottle of 500 capsules NDC 68382-161-10 in bottle of 1000 capsules NDC 68382-161-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules

PROPRANOLOL HYDROCHLORIDE Extended-release capsules USP, 80 mg are white to off-white, free flowing pellets filled in size '3' hard gelatin capsules with light blue colored cap printed with "ZA-58" in black ink and light blue body printed with "80 mg" in black ink and are supplied as follows: NDC 68382-162-16 in bottle of 90 capsules NDC 68382-162-01 in bottle of 100 capsules NDC 68382-162-05 in bottle of 500 capsules NDC 68382-162-10 in bottle of 1000 capsules NDC 68382-162-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules

PROPRANOLOL HYDROCHLORIDE Extended-release capsules USP, 120 mg are white to off- white, free flowing pellets filled in size'2' hard gelatin capsules with dark blue colored cap printed with "ZA-59" in black ink and light blue body printed with "120 mg" in black ink and are supplied as follows: NDC 68382-163-16 in bottle of 90 capsules NDC 68382-163-01 in bottle of 100 capsules NDC 68382-163-05 in bottle of 500 capsules NDC 68382-163-10 in bottle of 1000 capsules NDC 68382-163-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules

PROPRANOLOL HYDROCHLORIDE Extended-release capsules USP, 160 mg are white to off- white, free flowing pellets filled in size '1' hard gelatin capsules with dark blue colored cap printed with "ZA-60" in black ink and dark blue body printed with "160 mg" in black ink and are supplied as follows: NDC 68382-164-16 in bottle of 90 capsules NDC 68382-164-01 in bottle of 100 capsules NDC 68382-164-05 in bottle of 500 capsules NDC 68382-164-10 in bottle of 1000 capsules NDC 68382-164-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules Storage: Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light, moisture, freezing, and excessive heat. Dispense in a tight, light-resistant container. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


More pills like CAPSULE ZA 60 160 mg












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site